why choose us

First received: July 20, 2022

Clinical Trial: Sustained Release Oral Formulation for Treatment of Parkinson's Disease

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Idiopathic Parkinson Disease

Study Type: INTERVENTIONAL


Official Title: Sustained Release Oral Formulation for Treatment of Parkinson's Disease

Brief Summary: Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease.The aim of this study is to determine the efficacy of a novel oral carbidopa-levodopa formulation in achieving a sustained blood level of levodopa and carbidopa in PD.

Read more